Company / Revenue
Bausch & Lomb Corp Revenue History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$5.1B
FY2025
5-year range
$3.8B / $5.1B
FY2021-FY2025
Trend
+6.5%
vs FY2024
Sector context
#43 of 156
Health Care
What the data says
At $5.1B, Bausch & Lomb Corp's revenue ranks #43 of 156 in the Health Care sector. Improved from $3.8B to $5.1B over the past 2 years.
Based on SEC 10-K filings.
$5.1B in FY2025 with a 5-year CAGR of +8.4%.
Improved from $3.8B to $5.1B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +10.6%
- 5-Year CAGR
- +8.4%
- 10-Year CAGR
- -
Sector benchmark
#43 of 156 in Health CareTop 28% of 156This company $5.1B Sector average $19.0B
▼
-73.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +8.4%, indicating consistent growth.
- In FY2025, revenue increased 6.5% year-over-year.
- Ranks #43 out of 156 companies in the Health Care sector.
- Lowest revenue in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.74 (distress zone, below 1.8 threshold)
- Negative profit margin: -6.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.1B | +6.5% |
| FY2024 | $4.8B | +27.3% |
| FY2023 | $3.8B | -0.1% |
| FY2022 | $3.8B | +0.1% |
| FY2021 | $3.8B | +10.3% |
| FY2020 | $3.4B | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026